Published in J Am Acad Dermatol on December 01, 2001
Acrocyanosis: the Flying Dutchman. Vasc Med (2011) 0.93
Acrocyanosis: an overview. Indian J Dermatol (2013) 0.90
Remittent idiopathic necrotizing acrocyanosis - a rare entity. Indian J Dermatol (2010) 0.82
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem (1994) 2.51
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol (1986) 2.30
DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med (1995) 2.25
The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med (1999) 2.21
Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med (1999) 1.95
Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol (2007) 1.95
The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med (1989) 1.88
Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. Arch Dermatol (1993) 1.86
Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J Pediatr (2000) 1.74
A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol (1985) 1.67
Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest (1990) 1.67
Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA (1992) 1.60
Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol (1985) 1.60
Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading? Arch Dermatol (2000) 1.46
Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol (1993) 1.44
Induction of acantholysis in organ explant culture by penicillamine and captopril. Arch Dermatol (1989) 1.42
Paraneoplastic pemphigus in association with Castleman's disease. Br J Dermatol (2003) 1.32
Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol (1999) 1.23
Pemphigus and bullous pemphigoid. Lancet (1999) 1.20
Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest (1998) 1.20
Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest (1988) 1.14
The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol (1998) 1.12
Esophageal lichen planus: case report and review of the literature. Am J Surg Pathol (2000) 1.10
Periplakin and envoplakin are target antigens in canine and human paraneoplastic pemphigus. J Am Acad Dermatol (1999) 1.06
Paraneoplastic pemphigus: the role of tumours and drugs. Br J Dermatol (2001) 1.06
The use of human pemphigoid autoantibodies to study the fate of epidermal basal cell hemidesmosomes after trypsin dissociation. J Invest Dermatol (1985) 1.01
Definition of bullous pemphigoid antibody binding to intracellular and extracellular antigen associated with hemidesmosomes. J Invest Dermatol (1989) 0.98
Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol (1995) 0.95
Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. J Invest Dermatol (1984) 0.94
Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets. J Rheumatol (1987) 0.93
Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes. J Invest Dermatol (1985) 0.93
Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. J Clin Invest (1981) 0.92
Paraneoplastic pemphigus in children and adolescents. Br J Dermatol (2002) 0.92
Pemphigus and pemphigoid antigens are expressed in human amnion epithelium. J Invest Dermatol (1984) 0.90
Annular leukocytoclastic vasculitis associated with monoclonal gammopathy of unknown significance. J Am Acad Dermatol (2000) 0.89
Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol (1994) 0.89
Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. J Invest Dermatol (1983) 0.89
Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol (1986) 0.89
Pathogenesis of scleroderma. Current concepts. Int J Dermatol (1984) 0.89
Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol (1999) 0.88
Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome. Ann Thorac Surg (1997) 0.88
Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens. J Invest Dermatol (1990) 0.86
Paraneoplastic pemphigus with a pemphigus vegetans-like plaque as the only cutaneous manifestation. J Am Acad Dermatol (1998) 0.86
Linear immunofluorescence staining of the cutaneous basement membrane zone produced by pemphigoid antibodies: the result of hemidesmosome staining. J Am Acad Dermatol (1987) 0.86
Animal models for bullous pemphigoid. Clin Dermatol (1987) 0.86
Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol (1994) 0.85
Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex. J Invest Dermatol (1998) 0.84
Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest (1992) 0.84
An acquired form of epidermolysis bullosa without immunoreactants. Report of a case. J Am Acad Dermatol (1985) 0.84
Paraneoplastic pemphigus: oral involvement as the sole manifestation. Acta Derm Venereol (1996) 0.84
Calcium enhances the sensitivity of immunofluorescence for pemphigus antibodies. J Invest Dermatol (1987) 0.83
Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil. Arch Dermatol (1999) 0.83
Vancomycin-associated linear IgA bullous dermatosis. Ann Intern Med (1998) 0.83
Autoantibodies to desmoplakin I and II in patients with erythema multiforme. J Exp Med (1995) 0.83
Subacute cutaneous lupus erythematosus associated with interferon beta-1a. Lancet (1998) 0.83
Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. J Immunol (1986) 0.82
Ultrastructural studies of acantholysis induced in vivo by passive transfer of IgG from endemic pemphigus foliaceus (Fogo Selvagem). J Invest Dermatol (1989) 0.82
Serum CA-125 screening for ovarian cancer in patients with dermatomyositis. Gynecol Oncol (1997) 0.82
Histologic features of paraneoplastic pemphigus. Arch Dermatol (1992) 0.82
Infliximab for peristomal pyoderma gangrenosum. Br J Dermatol (2003) 0.81
Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris. Clin Exp Immunol (2010) 0.81
Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. J Am Acad Dermatol (1999) 0.81
Paraneoplastic pemphigus with clinical features of erosive lichen planus associated with Castleman's tumor. Dermatology (1995) 0.81
Mucous membrane pemphigoid presenting with isolated esophageal involvement: a case report. Gastrointest Endosc (2000) 0.81
Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid. Arch Dermatol (1983) 0.81
Paraneoplastic dermatomyositis presenting as erythroderma. J Am Acad Dermatol (1998) 0.81
[ATPase positive epidermal Langerhans cells: inhibition of ATPase by ammonium bituminosulfonate (Ichthyol) and pix lithanthracis]. Hautarzt (1992) 0.81
Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature. Medicine (Baltimore) (1999) 0.81
The calcium-sensitive epitope of pemphigus foliaceus antigen is present on a murine tryptic fragment and constitutes a major antigenic region for human autoantibodies. J Invest Dermatol (1991) 0.80
Paraneoplastic pemphigus with cutaneous and serological features of pemphigus foliaceus. Br J Dermatol (1999) 0.80
The Marfan syndrome and the cardiovascular surgeon. Eur J Cardiothorac Surg (1996) 0.80
Cicatricial pemphigoid. Dermatol Clin (1993) 0.80
Autoimmune injury of squamous epithelium by pemphigus autoantibodies. Br J Dermatol (1984) 0.79
Herpes gestationis. J Autoimmun (1991) 0.79
Inhibition of Langerhans cell ATPase and contact sensitization by lanthanides--role of T-suppressor cells. J Invest Dermatol (1991) 0.79
Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies. Cytogenet Cell Genet (1993) 0.79
Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus. J Am Acad Dermatol (2001) 0.79
Pemphigus foliaceus antigen: characterization of a keratinocyte envelope associated pool and preparation of a soluble immunoreactive fragment. J Invest Dermatol (1989) 0.78
Epidermal proteins. I. Differential extraction and quantitative polyacrylamide gel-electrophoretic analysis of basal spinous-cell proteins of neonatal mouse epidermis. Arch Dermatol Res (1985) 0.78
Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris. Clin Exp Immunol (2005) 0.78
Localized mucosal involvement and severe pulmonary involvement in a young patient with paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol (1998) 0.78
Lichenoid eruption following hepatitis B vaccination: first North American case report. Pediatr Dermatol (2001) 0.78
Bullous pemphigoid and pemphigus vulgaris. Ann Allergy (1983) 0.78
No evidence of human herpesvirus 8 infection in patients with paraneoplastic pemphigus, pemphigus vulgaris, or pemphigus foliaceus. J Invest Dermatol (1998) 0.78
Bullous skin diseases. Curr Opin Immunol (1995) 0.78
Elevated serum levels of interleukin-6 in paraneoplastic pemphigus. J Invest Dermatol (1999) 0.77
Bullous pemphigoid autoantibodies are markers of corneal epithelial hemidesmosomes. Invest Ophthalmol Vis Sci (1987) 0.77
Poststroke pruritus. Stroke (1999) 0.77
Paraneoplastic pemphigus: a case of long-term survival associated with systemic lupus erythematosus and polymyositis. Dermatology (1999) 0.77
Diffuse bullous eruption in a 3-month-old infant. Ann Allergy (1987) 0.76
Drug-induced pemphigus. Dermatol Clin (1993) 0.76
Successful therapy for bullous pemphigoid with mycophenolate mofetil. J Am Acad Dermatol (1998) 0.76
Making sense of antigens and antibodies in pemphigus. J Am Acad Dermatol (1999) 0.76
Immunopathology of pemphigus vulgaris, bullous pemphigoid and related bullous dermatoses. Clin Immunol Rev (1984) 0.76
Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol (1997) 0.76
Pernicious anemia and widespread absence of gastrointestinal endocrine cells in a patient with autoimmune polyglandular syndrome type I and malabsorption. J Clin Endocrinol Metab (2006) 0.76